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Abstract
To elucidate the transcriptional landscape that regulates human lymphoid commitment during 
postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across 
human bone marrow and thymic progenitors spanning the earliest stages of B and T lymphoid 
specification. Over 3000 novel long non-coding RNA genes (lncRNAs) were revealed through the 
analysis of these rare populations. Lymphoid commitment was characterized by lncRNA 
expression patterns that were highly stage-specific and more lineage-specific than protein coding 
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patterns. Protein-coding genes co-expressed with neighboring lncRNA genes were enriched for 
ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global 
lncRNA expression patterns independently revealed new developmental relationships between the 
earliest progenitors in the human bone marrow and thymus.
INTRODUCTION
Long non-coding RNAs (lncRNAs) comprise a key component of the repertoire of 
regulatory elements that control cell differentiation1. However, the lncRNA landscape of 
human lymphoid commitment is unknown; thus knowledge of the transcriptional programs 
that launch human lymphopoiesis and regulate the subsequent fate decision between the T 
and B cell lineages is incomplete. We assembled a lncRNA catalog through whole 
transcriptome sequencing of rare hematopoietic stem cell (HSC) and lymphoid progenitor 
populations that encompass the earliest stages of B and T lineage commitment in the human 
bone marrow (BM) and thymus.
HSCs and lymphoid progenitors in both the BM and thymus express the surface antigen 
CD34 (refs.2,3). Although various immunophenotypic subsets of the CD34+ progenitors 
have been identified, the exact developmental relationships between these populations 
remain undefined. In particular, the identity of the dominant BM progenitor that migrates to 
the human thymus and initiates T cell differentiation remains an unanswered question due to 
the inherent limitations of functional assays of human progenitors. Expression of the cell 
surface antigen CD10 has long been used to define so-called “common lymphoid 
progenitors” (CLPs), which have been thought to represent the first stage of human 
lymphoid commitment in the BM and cord blood because of their broad ability to generate 
all lymphoid lineages2. The CD10+ progenitors have also been postulated to be the BM-
derived precursors that seed the thymus because of their ability to generate T cells in 
culture2,4,5. Recently, we identified a lymphoid progenitor population that lacks CD10 
expression but nonetheless possesses robust B, T and natural killer (NK) lymphoid potential; 
these CD34+CD38+CD45RA+CD10− CD62Lhi lineage-negative (lin−) cells were termed 
lymphoid-primed multipotent progenitors (LMPPs) because of functional similarity to the 
previously described Flt3+ murine LMPPs which lack erythroid and megakaryocytic 
potential6.
B lymphoid commitment begins in the BM; the cell surface co-expression of CD19 and 
CD34 defines a fully B-committed progenitor (BCP) that lacks the potential for any other 
lymphoid (NK or T) lineages7. T lymphoid commitment is initiated by the arrival of BM-
derived precursors in the thymus. CD34+ thymic progenitors constitute <1% of all 
thymocytes8 and can be further fractionated based on CD7 and CD1a expression8,9. Two 
progenitor populations in the thymus with both lymphoid and myeloid potential have been 
described; the CD34+CD7−CD1a− progenitors (~5% of CD34+ thymocytes), and the 
CD34+CD7+CD1a− progenitors (~30–50% of CD34+ thymocytes)8,9. The degree of myeloid 
potential varies between these two progenitors, and the developmental relationship between 
them is unknown8,9. Upregulation of CD1a expression marks the third thymic progenitor 
population, the CD34+CD7+CD1a+ cells that represent the earliest fully T lineage-
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committed progenitor stage9. These latter cells generate CD4+CD8+ (double-positive, DP) 
thymocytes, which comprise the predominant population in the thymus, and further 
differentiate into single-positive (either CD4+ or CD8+) T cells that egress from the thymus 
to constitute mature peripheral T lymphocytes3,9.
We here demonstrate that the transcriptional repertoire of the lymphoid progenitors in BM 
and thymus, and the HSCs from which they are generated, is comprised of at least 9,400 
lncRNA genes, over a third of which represent previously undiscovered genes. Sample 
clustering analysis and Bayesian polytomous model selection revealed distinct global 
lncRNA expression patterns that corresponded to early lymphoid commitment or lineage (B 
or T) specification. Global lncRNA expression patterns independently revealed 
developmental relationships between BM and thymic progenitors, which supported the 
conclusions that uncommitted thymic progenitors directly arise from BM-derived HSCs 
and/or LMPPs while CD10+ CLPs and subsequent B cell differentiation proceed through a 
separate pathway, and that CD34+CD7−CD1a− progenitors represent the earliest 
developmental stage of thymopoiesis. Our data constitute a resource for the elucidation of 
lncRNA mechanisms that regulate the earliest stages of human lymphopoiesis.
RESULTS
Novel lncRNAs revealed in HSC and lymphoid progenitors
To annotate novel lncRNAs during human lymphoid commitment, we performed RNA-Seq 
of 10 distinct cell types isolated by flow cytometry. From BM, we isolated CD34+CD38−lin− 
cells, a population highly enriched for HSCs, as well as three lymphoid progenitor 
populations; LMPPs, CLPs (CD34+CD38+CD10+CD45RA+lin−) and fully B cell-committed 
progenitors (BCPs, CD34+CD38+CD19+). From thymus we isolated three 
CD34+CD4−CD8− subsets; Thy1 (CD34+CD7−CD1a−), Thy2 (CD34+CD7+CD1a−) and 
Thy 3 (CD34+CD7+CD1a+), as well as fully T cell-committed populations; CD4+CD8+ 
(Thy 4), CD3+CD4+CD8− (Thy5) and CD3+CD4−CD8+ (Thy6). (Fig. 1a, Supplementary 
Fig.1a,b). We assembled the transcriptome by aligning and pooling reads from twenty 
samples (n = 2 biological replicates per cell type) to identify individual transcripts. 
Expression patterns for protein-coding genes known to be specifically expressed in 
hematopoietic stem/progenitor cells (HSPCs) or lymphoid lineages (B, T, or both) 
(Supplementary Fig.1c) were consistent with published studies7,10,11,12, validating our 
isolation and sequencing methods.
LncRNAs were identified using an ab-initio assembly pipeline (Fig. 1b). The final lncRNA 
annotation (Supplementary Table 1) used throughout the paper was comprised of long (> 
200 bp), spliced transcripts with no sense exonic overlap with protein-coding genes. 
Analysis by CPAT13and PhlyoCSF14 confirmed these transcripts to be largely devoid of 
protein-coding potential (Supplementary Fig.1d). This comprehensive annotation comprised 
a total of 18,268 lncRNA genes, with 3,880 novel lncRNA genes not annotated in existing 
lncRNA databases15,16. Owing to the generation of multiple transcripts from each gene 
through alternative splicing, a total of 6,851 novel lncRNAs transcripts were detected, of 
which 4,661 were transcribed from previously unannotated gene loci while 2,190 
represented novel isoforms generated from previously annotated loci.
Casero et al. Page 3
Nat Immunol. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Using unique whole-genome alignments of our RNA-Seq libraries to estimate expression 
levels on the final merged annotation (protein-coding and lncRNA genes), we found that 
9,444 lncRNA genes and 3,348 novel lncRNA genes were expressed at >1 FKPM in at least 
one sample (Fig.1c, gene expression estimates listed at NCBI’s Gene Expression Omnibus 
[GSE69239]). Supplementary Table 2 lists the number of genes expressed in each cell type. 
Consistent with the strong correlation of gene expression between replicate samples (mean 
correlation coefficient = 0.95, standard deviation = 0.02, Supplementary Fig. 2a), 80% 
(2688 /3348) of novel lncRNA genes were expressed (FPKM>1) in both replicates of at least 
one cell type.
To validate the RNA-Seq expression data, a subset of B cell-specific lncRNAs was assessed 
by qPCR, (n = 2 biological replicates per cell type, including a replicate that was separate 
from the samples used for RNA-Seq). High concordance was observed between qPCR and 
RNA-Seq expression results across the ten cell types, for each of these genes (mean 
correlation = 0.92, standard deviation = 0.07, Supplementary Fig. 2b).
Among the novel lncRNA genes expressed at >1 FKPM in at least one sample, 2,652 were 
intergenic while 696 flanked a protein-coding gene in a divergent orientation (overlapping 
with a protein-coding gene on the antisense strand). The size distribution of novel lncRNA 
transcripts was similar to that of previously annotated lncRNAs15,16 (Supplementary Fig. 
2c). Of note, novel lncRNA transcripts, irrespective of whether they were transcribed from 
previously unnannotated or annotated gene loci, were more abundantly expressed in these 
hematopoietic populations than were previously annotated lncRNAs (Fig. 1d, 
Supplementary Fig.2d).
Analysis of RNA-Seq data from Illumina’s Human Body Map (Supplementary Table 3), 
revealed that the novel lncRNA genes identified from our data were highly specific to the 
HSC and/or lymphoid populations studied in this current report (Fig. 1e). Interestingly, 
among the 3,109 novel lncRNA genes expressed in the six thymic populations, less than a 
third overlapped with a recently published catalog of lncRNAs derived from transcriptional 
profiles of unfractionated thymocytes and T cell acute lymphoblastic leukemia cells17.
To further characterize the lncRNA expression signature obtained from our RNA-Seq 
analysis, we analyzed the transcription start sites (TSS) of the novel lncRNAs for the 
presence of histone modifications. Actively transcribed lncRNA genes have been shown to 
be associated with, among others, promoter- (histone 3 lysine 4 trimethylation [H3K4me3]) 
or enhancer-associated (histone 3 lysine 4 monomethylation [H3K4me1]) histone 
modifications18,19. Although it has been previously shown that histone modifications are 
regulated during differentiation, only a fraction is subjected to significant dynamic 
changes20. Therefore, as low cell numbers render ChIP-sequencing of the rare populations 
used in this study largely unfeasible, we used publically available H3K4me1 and H3K4me3 
ChIP-Seq data for hematopoietic progenitor (CD34+) and lymphoid cell populations 
(Supplementary Table 3)21. In addition, RNA-Seq libraries for these same populations were 
downloaded and re-analyzed to identify the populations that were transcriptionally similar to 
the specific progenitors used to generate our RNA-Seq dataset (Supplementary Fig. 3). 
ChIP-Seq data from three populations were thus chosen for analysis: whole thymic tissue, 
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CD19+ primary B lymphocytes, and mobilized peripheral blood HSPCs (defined as either 
CD34+ or CD133+) (Supplementary Table 3).
Over a third of the novel lncRNA TSSs (37%) showed overlap with statistically significant 
peaks (Supplementary Methods) for at least one type of histone modification, a proportion 
similar to that of previously annotated lncRNAs associated with such histone modifications 
in these datasets (37.5%) as well as in a published analysis of epigenetic modifications22. 
H3K4me1 modifications showed a broader density distribution around TSSs when compared 
with H3K4me3 modifications (Fig. 2a,b). Protein-coding gene TSSs tended to show high 
density of H3K4me3 modifications (low H3K4me1/H3K4me3 ratio) in HSPCs and 
lymphoid cells, a feature commonly associated with promoter regions. On the other hand, 
lncRNA TSSs tended to show high H3K4me1/H3K4me3 ratios, a feature commonly 
associated with enhancer regions18,19. H3K4me1/H3K4me3 ratios for TSSs with 
overlapping histone modification peaks are depicted in Fig. 2c (data for individual TSSs 
listed in Supplementary Table 4).
In the case of protein-coding genes, highly expressed transcripts were associated with a 
higher level of histone modifications compared to transcripts that were not expressed, or a 
set of randomly chosen transcripts (Fig. 2d). In contrast, in the case of lncRNA genes, cell 
type-specific transcripts were associated with the highest density of histone modifications 
(Fig. 2d). In summary, our results indicate that the transcriptional landscapes of human 
HSCs and lymphoid progenitors are characterized by numerous previously undescribed 
lncRNAs that are unique to these cell types.
Correlation between lncRNA and coding gene expression
To investigate co-expression patterns between lncRNA and protein-coding genes during 
lymphoid differentiation, we computed pairwise expression correlations between genes 
across all RNA-Seq samples. We first analyzed trans correlations of expression (defined as 
pairs consisting of genes separated by a distance >1 Mb, or located in different 
chromosomes). Expression of lncRNA genes tended to be more positively than negatively 
correlated with protein-coding genes in trans (4.0% of pairs had Spearman correlation 
coefficient |rho| (rs) >0.5, vs. 2.7% rs < −0.05, out of a total of 215 million trans-correlations 
tested). Consistent with previous reports2, the same tendency toward positive correlation was 
observed for pairs of protein coding-protein coding genes in trans (Supplementary Table 5). 
In all cases, the bias to positive correlations was significantly higher than that obtained from 
a control set of trans correlations, where the expression of protein-coding genes was 
randomly shuffled (Fig. 3a).
We then analyzed cis correlations of expression (defined as pairs consisting of genes located 
within a genomic window of 100 kb). Interestingly, we found a higher proportion of positive 
correlations among cis correlations than among trans correlations, in the cases of both 
lncRNA-protein coding and protein-coding–protein-coding pairs (13.3% and 15.0% 
respectively for cis vs 4.0% and 7.3% respectively for trans, for rs >0.5). In all sets of gene 
pairs (protein-coding–protein-coding, protein-coding–lncRNA, and protein-coding–novel 
lncRNA), positive but not negative cis-correlations were higher than those obtained from 
random controls (Fig. 3a). The highest proportion of positive and extreme positive 
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correlations were found when we restricted the analysis to novel lncRNA genes 
(Supplementary Table 5).
Gene Ontology analysis of the protein coding genes that showed strong positive cis-
correlations with lncRNA genes revealed enrichment for genes involved in the regulation of 
lymphocyte development and proliferation, hematopoiesis and immune processes (Fig. 3b). 
In contrast, genes showing negative cis-correlations were not statistically associated with 
these functional annotations (Fig. 3b).
To gain further insight into the co-expression signature of genes under strong transcriptional 
regulation, we delineated the expression profiles of 6,793 genes (protein-coding and 
lncRNA), which were differentially expressed in at least one pairwise comparison among the 
ten cell types (fold change > 2, false discovery rate <5%). Model-based gene clustering23 
was used to obtain twenty non-redundant expression profiles (Profiles 1–20), which could be 
classified into seven broad groups (Groups I–VII, Fig. 3c, Supplementary Table 6). 
Interestingly, four specific profiles showed significant enrichment for lncRNA genes (P < 
0.05 when compared with the proportion of lncRNA genes among all differentially 
expressed genes): those that peaked with B lineage commitment (Profile 7); peaked at the 
Thy3 stage of T cell commitment (Profile 13); and were upregulated in both B and T 
lymphoid populations relative to HSCs (Profiles 14 and 15).
Differentially expressed lncRNA genes were significantly enriched for loci that neighbored 
protein-coding genes involved in transcriptional regulatory mechanisms, T and B cell 
immune responses, and HSC migration (analysis based on the GREAT24 tool, 
Supplementary Fig. 4, Supplementary Tables 7,8). Moreover, lncRNA genes with cell type-
specific expression patterns were enriched for loci that neighbored protein-coding genes 
with similar cell type specificity (Supplementary Fig. 4). For instance, HSPC (Group I) 
lncRNA genes were enriched for loci that neighbored HSPC specific protein-coding genes. 
In summary, global co-expression analysis and gene-expression profiling suggest an 
important and previously unappreciated role for lncRNAs in lymphoid commitment from 
HSC, and T and B cell specification.
LncRNA-based classification of BM and thymic progenitors
Sample clustering of transcriptomes was next used to investigate developmental 
relationships between lymphoid progenitors in the BM and thymus. Samples were clustered 
based on genes (both protein-coding and lncRNA genes) that were differentially expressed 
in at least one pairwise comparison of the ten cell types (“Tree 1”, Fig. 4a). CD34+ thymic 
progenitors (Thy1, Thy2, and Thy3) segregated with all four CD34+ populations in the BM 
(HSCs, LMPPs, CLPs and BCPs) rather than late (CD34−) thymic populations (Thy4, Thy5, 
and Thy6). Moreover, within the branch containing CD34+ progenitors, early thymic 
progenitors (Thy 1 and Thy 2) sub-clustered with HSCs and LMPPs while CLPs and BCPs 
formed a separate group. This phylogeny of samples was not affected by variations in FDR 
and fold change criteria for gene selection, or the inclusion of publically available RNA-Seq 
datasets from a wide range of tissues, indicating the robustness and validity of this clustering 
approach (Online methods, Supplementary Fig. 5a,b).
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We next constructed sample trees based on differentially expressed genes from the following 
classes: Tree 2, protein coding genes (Fig. 4b); Tree 3, all lncRNA genes (novel and 
previously annotated lncRNAs, Fig. 4c); and Tree 4, novel lncRNA genes (Fig. 4d). Of note, 
the clustering of B lineage-skewed (CLP and BCP) progenitors varied among the trees, 
whereas CD34+ thymic progenitors (Thy1, 2 and 3) clustered with HSCs and LMPPs in all 
four trees. Protein-coding gene expression profiles clustered CLPs and BCPs with the other 
CD34+ cells in the BM (HSCs and LMPPs) and the thymus (Thy1, Thy2, and Thy3). In 
contrast, lncRNA gene expression profiles (Trees 3 and 4) segregated B lineage-skewed cells 
in a cluster distinct from all thymic populations (Thy 1–6), indicating that lncRNAs are 
expressed in a highly lineage (B versus T) specific manner (Fig. 4c,d). To test whether the 
difference between trees based on protein-coding and lncRNA genes was due either to a 
difference in the number of protein-coding (5,611) and lncRNA (1,182) genes, or to 
differences in expression levels of these two types of genes, we generated trees using 
randomly selected sets of differentially expressed genes of the same size and similar 
expression levels. In all cases, the observed trees remained unchanged, indicating that the 
differences between protein-coding and lncRNA trees reflected actual differences in the 
lineage specificity of expression of the two classes of genes. Overall, the clear proximity of 
early thymic progenitor transcriptomes (Thy1, Thy2) to HSCs and LMPPs rather than to 
CLPs suggests the pre-commitment thymic progenitors that give rise to the T lineage 
directly arise from BM-derived multipotent HSCs and/ or LMPPs, and that the CLP stage 
marks the launch of a transcriptionally separate program, which largely overlaps with that of 
fully B lineage committed CD19+ lymphoid progenitors.
To further dissect the transcriptional relationships between the earliest BM and thymic 
progenitors, we used Bayesian polytomous model selection, an algorithm that has previously 
been used to study transcriptional changes at known differentiation branch points among 
cord blood progenitors25. This approach enabled transcriptional proximities between 
selected early progenitor cell types to be scrutinized in a highly stringent statistical context, 
avoiding the influence of transcriptomes of fully lineage committed populations (BCP, Thy3, 
Thy4, Thy5, and Thy6). Model selection was first performed using both protein-coding and 
lncRNA genes (n = 38613 genes) (Fig. 5a). For a given combination of any three cell types, 
each gene was assigned to either the null model (expression similar in all 3 cell types) or one 
of the alternative (non-null) models (expression different in at least one, and possibly all, cell 
types) (Fig. 5a). The total number of genes classified in non-null models (“classified genes”) 
for a given combination of samples can be interpreted as an inverse measure of the 
transcriptional similarity between the cell types in the combination. As predicted, a 
markedly lower number of classified genes (5.5 fold lower) was seen with the Thy4-Thy5-
Thy6 combination (closely related differentiated T lineage populations) than with the HSC-
BCP-Thy4 combination (members from distinct lineages).
We then applied model selection to the least committed BM (HSC, LMPP, and CLP) and 
thymic (Thy1 and Thy2) cell types. Gene ontology analysis of classified genes confirmed 
the ability of this approach to appropriately identify the core transcriptional differences 
between cell types within a given combination, for example, T cell differentiation genes 
were significantly enriched among the genes expressed uniquely in thymic progenitors 
(Supplementary Fig. 6).
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Less than 3% of all genes were found to be classified in non-null models when the earliest 
progenitors were studied (HSC, LMPP, CLP, Thy1 and Thy2), demonstrating the close 
biological similarities between these cell populations, and the stringent model assignment 
criteria used. However, combinations that included the CLP cell type contained markedly 
higher numbers of classified genes than those that did not include this cell type (Fig. 5a, 
Supplementary Table 9), confirming that CLPs have a transcriptional program that is distinct 
from that of uncommitted thymic progenitors (Thy1 and Thy2), HSCs, and LMPPs. 
Interestingly, the least number of classified genes were seen for the HSC-LMPP-Thy1 
combination. The striking similarity between these three cell types strongly suggests close 
developmental relationships for LMPPs and Thy1 to HSCs, and points toward Thy1 as the 
most primitive progenitor in the human thymus.
When the input set of genes for Bayesian polytomous analysis was restricted only to 
lncRNA genes (n = 18,268 genes) (Fig. 5b, Supplementary Table 9), the transcriptional 
relationships seen between the progenitors were recapitulated; differences in lncRNA gene 
expression were dominated by the presence of CLP. These data demonstrate that the 
exquisitely cell-type specific nature of lncRNA expression in BM and thymic progenitors 
can be used to define developmental relationships, independent of protein coding gene 
expression.
Co-expression modules of LncRNA and coding genes
Correlation based approaches are widely used to infer the function of lncRNAs. These 
include co-expression analysis (i.e. putative functions of a given lncRNA are inferred based 
on those protein-coding genes that are highly co-expressed with the lncRNA - guilt by 
association), and functional associations based on the cell type specificity of lncRNAs26. 
Here, we employed weighted gene co-expression network analysis (WGCNA), which allows 
combining these two strategies27. WGCNA first identifies modules of highly co-expressed 
genes, from which modules with cell type-specific expression profiles can be easily selected. 
Additionally, individual genes within these modules can be ranked based on module 
membership (a measure of how similar the expression profile of a gene is to that of the 
module). Screening for genes with high module membership has been shown to be a useful 
strategy to identify genes of biological interest28.
Of the 45 modules identified by WGCNA in our samples, five were chosen for further 
analysis as they demonstrated significant lineage or differentiation stage-specific profiles (P 
< 0.05) (Fig. 6a,b): HSPC module (all CD34+ cells), B lineage module (CLP and BCP), T 
lineage module (Thy1–6), lymphoid module (both B lineage [CLP, BCP] and T lineage 
[Thy2–Thy4] populations), and early thymic progenitor module (Thy1–3). These modules 
contained protein-coding genes known to be specific to each of the cell types; these include, 
respectively, HSPCs (CD34, ERG), B lineage (PAX5, EBF1), T lineage (BCL11B, CD3), 
lymphoid (RAG1, RAG2), and early thymic progenitor cells29 (NOTCH1). The individual 
genes in each module were then ranked based on module membership (Supplementary Table 
10).
To aid the utilization of our database as a resource, we provide two examples of how the 
above approach can be used to identify interesting candidate lncRNA and lncRNA-protein 
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coding gene co-expression associations for further functional studies (circos plots in Fig. 
6c,d). The first strategy (coding to non-coding association, Fig. 6c) involves selection, from 
a module of interest, of protein-coding genes known to be important in a specific functional 
process. Interesting lncRNA gene candidates are then identified based on how strongly their 
expression profile correlates with that of the selected protein-coding genes. The second 
strategy (non-coding to coding association, Fig. 6d) involves selection of candidate lncRNA 
genes based on module membership and expression strength (since high expression may 
facilitate functional characterization). Associated protein-coding genes are then identified 
based on how strongly their expression profile correlates with that of the selected lncRNA 
genes. Supplementary Table 10 lists the lncRNA-protein coding gene associations identified 
when the five chosen modules were analyzed using these two strategies. Overall, the 
WGCNA results provide a searchable resource to identify lncRNA candidates and generate 
hypotheses for functional studies to elucidate the role of lncRNAs in lymphopoiesis.
DISCUSSION
To the best of our knowledge, this report represents the first integrated transcriptional map of 
protein coding and lncRNA elements underlying the initial phases of post-natal lymphoid 
commitment in the human BM and thymus.
A recent evolutionary study showed significant differences between the repertoires of 
murine and human lncRNAs30. Of the few studies performed in human hematopoiesis, most 
have analyzed cord blood progenitors or fully differentiated peripheral blood 
lymphocytes25,31, which are functionally and immunophenotypically different from the BM 
and thymic progenitors underlying steady state postnatal lymphoid commitment6. 
Furthermore our conceptual framework of lymphoid development in the BM and thymus is 
largely based on the lineage potential of isolated progenitors using in vitro or 
xenotransplantation assays. However, the non-physiological nature of these assays create 
significant challenges when interpreting such studies of human lymphopoiesis. Thus, in the 
current report we examined the relationship between BM and thymic progenitors through the 
use of global gene expression profile analyses of purified unperturbed cells. Even among 
these closely related cell types, analysis of global lncRNA expression profiles uncovered 
new relationships, suggesting an important role for lncRNAs during the initial stages of 
lymphopoiesis.
Two recent studies annotated lncRNAs in unfractionated thymocytes17, and thymic 
progenitors stimulated ex vivo with Notch ligands32. While approximately one fourth of the 
lncRNAs expressed in thymic progenitors in our dataset overlapped with those reported in 
these studies, we identified over two thousand unique, previously undescribed lncRNA 
genes in the thymic transcriptome. The use of purified subpopulations of CD34+ progenitors 
(which are extremely rare in whole thymic tissue) in our study, the predominance of 
leukemic samples in the datasets used for defining lncRNAs in other studies, and the 
transcriptional changes related to non-physiological conditions in culture may account for 
the differences in the repertoires of lncRNA genes described in the current and previous 
reports. Our results underscore the importance of defining the lncRNAs de novo in 
unmanipulated purified rare progenitor populations.
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To date, the unmapped nature of lncRNAs underlying human lymphoid commitment has 
represented a substantial obstacle to the dissection of transcriptional circuits regulating 
lymphopoiesis. The database presented here of annotated lncRNAs expressed in the rare 
progenitors that mark the initiation of B and T lineage divergence has allowed the cataloging 
of protein-coding–lncRNA gene associations, and the identification of developmental 
relationships between these progenitor stages, thus providing a resource for parsing the 
lncRNA circuitry in normal lymphopoiesis, and understanding aberrations of these 
mechanisms in immune deficiencies and lymphoid malignancies.
Online METHODS
Isolation and RNA extraction from bone marrow and thymic progenitors
Anonymous normal human thymi were obtained via the UCLA Translational Pathology 
Core Laboratory and the CHLA cardiovascular thoracic surgery department. Bone marrow 
(BM) was obtained from donors via ALLCELLS, Alameda, CA. All tissues were collected 
and used in accordance with UCLA and CHLA Institutional Review Board guidelines. The 
magnetic activated cell sorting (MACS) system (Miltenyi Biotec) was used to enrich CD34+ 
cells from BM and thymus prior to isolation of CD34+ subsets by flow cytometry. BM 
CD34+ cells were incubated with the following antibodies: CD34-APC-Cy7 (581), CD38-
APC (HIT2), CD10-PE-Cy7 (HI10a), CD62L-PE (DREG-56), CD45RA Percp-cy5.5 
(HI100) (all from Biolegend), as well as the following FITC-labeled lineage depletion 
antibodies: CD3 (SK7), CD14 (M5E2), CD19 (4G7), CD56 (MY31), and CD235a (GA-R2)
(Becton Dickinson). CD19 was not included in the lineage depletion cocktail used for 
sorting BCPs. An unstained control was used to set gates. CD34+ enriched thymic cells were 
incubated with CD34 Percp-cy5.5 (8G12), CD7 FITC (4H9), CD1a PE (HI149) and APC-
labeled CD4 (RPA-T4) and CD8 (SK1). To isolate DP and SP thymocytes, non-CD34 
enriched thymic cells were incubated with CD3 APC (UCHT1), CD4 FITC (RPA-T4), and 
CD8 Percp (SK1) (all from BD). Dead cells were gated out using 4′,6-diamidino-2-
phenylindole (DAPI). FMO (fluorescence minus one) controls were used to set gates for 
isolating thymic cells. The following immunophenotypic definitions were used to isolate 
progenitors from BM CD34+ cells: CD34+CD38−lin− (HSCs), 
CD34+CD45RA+CD38+CD10− CD62Lhi lin− (LMPPs), CD34+CD38+CD10+CD45RA+ 
lin− (CLPs) and CD34+CD38+CD19+lin− (BCPs); thymic CD34+ cells: 
CD34+CD7−CD1a−CD4−CD8− (Thy1), CD34+CD7+CD1a−CD4−CD8− (Thy2), 
CD34+CD7+CD1a+CD4−CD8− (Thy3); and thymic CD34− cells: CD4+CD8+ (Thy4), 
CD3+CD4+CD8− (Thy5), and CD3+CD4−CD8+ (Thy6) (Supplementary Fig.1a, b). All 
populations were isolated on a FACSAria (355, 405, 488, 561 and 633 nm lasers) (BD 
Immunocytometry Systems).
Progenitor populations were isolated for RNA-Seq from 2 donors (2 biological replicates) 
for bone marrow and thymus (separate donors for bone marrow and thymus). Fresh samples 
were used for both replicates of the bone marrow and for one replicate of the thymus. Cells 
cryopreserved post MACS were thawed and used for isolation of subsets by flow cytometry 
for the other replicate of the thymus. Progenitors were isolated from fresh samples for qPCR 
from additional donors for bone marrow and thymus (separate donors for bone marrow and 
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thymus). The Trizol method (Mirneasy RNA extraction kit, Qiagen) was used to extract 
RNA from all samples. The RNA 6000 Pico kit (Agilent technologies) was used to assess 
RNA integrity prior to library preparation.
RNA-Seq library preparation and sequencing protocol
The Ovation RNA- Seq System V2 (NuGen), which uses oligo dT as well as random 
primers for reverse transcription, was used to convert 6–10 ng of total RNA (not selected for 
polyadenylation) into amplified cDNA (linear amplification). The cDNA was sheared using 
a S220 focused ultrasonicator (Covaris) to generate an average fragment size of 350 base 
pairs. 900 ng of sheared cDNA was converted into sequencing libraries using the Encore 
Rapid DR Multiplex kit (NUGen), which were then sequenced on an Illumina Hiseq 2000 
sequencer (paired end 100 base pair sequencing). A total of 541 million paired-end reads 
were generated (on average 27 million reads for each sample). Raw sequence files have been 
deposited at NCBI’s Gene Expression Omnibus (GSE69239).
RNA-Seq and ChIP-Seq data analysis
The STAR33 aligner was used to align paired end reads to the human genome. Reference 
Annotation Based Transcript (RABT) assembly34 was used to assemble the transcriptome. 
Alignment files for each of our samples as well as those derived from publicly available 
RNA-Seq datasets were analyzed with HTSeq35, using our gene annotation file to generate 
gene-level counts for each sample. Pairwise expression correlations between protein coding 
and lncRNA genes were computed using a strategy that was previously described for the 
characterization of the Gencode lncRNA catalog15. Gene clustering of differentially 
expressed genes was performed by means of MBCluster.Seq23. GREAT24 was used to 
analyze functional annotations of protein-coding genes whose regulatory domains 
overlapped lncRNA gene loci. Pair-wise differential expression was performed with 
DESeq36. Bayesian model polytomous selection and WGCNA were done as previously 
described25,27. Peak detection and signal intensity analyses for ChIP-seq data were done 
using MACS237 and HOMER38 respectively. A detailed description of the RNA-Seq and 
ChIP-Seq analysis methods is provided in the supplementary methods section.
Quantitative Polymerase Chain Reaction (PCR)
Predesigned primers (Qiagen) were used for lnc-UBE2N-2 (catalog no. LPH15913A-200), 
lnc-FBXO31-1 (catalog no. LPH23574A), AC006129.1 (catalog no. LPH25998A), 
RP11-301G19.1 (catalog no. LPH06790A), and ACTB (catalog no. PPH00073G). Primers 
for LINC00544, BMThy_chr2_0447, BMThy_chr2_1049, and BMThy_chrX_ were 
designed using Primer3Plus software (http://www.bioinformatics.nl/cgi-bin/primer3plus/
primer3plus.cgi) and synthesized by Life Technologies (Supplementary Table 11 lists primer 
sequences). The RT2 SYBR Green ROX qPCR Mastermix (Qiagen) was used for reactions 
involving predesigned primers (RT2 lncRNA qPCR assay). The Power SYBR Green PCR 
master mix (Life Technologies) was used for reactions involving primers designed with 
Primer3. cDNA prepared using the Ovation RNA- Seq System V2 or the Superscript Vilo 
CDNA synthesis kit (Life Technologies) was used as input for all PCR reactions. All 
reactions were run in triplicate using the Applied Biosystems 7900 HT Real Time PCR 
system (Life Technologies). Thermocycling parameters: 10 min at 95 °C followed by 40 
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cycles of 15 s at 95 °C and 60 s at 60 °C. Gene expression was calculated relative to ACTB 
expression using the ΔCt method. A Pearson correlation coefficient between qPCR and 
RNA-Seq gene expression measurements was calculated for each gene.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Human HSC and lymphoid transcriptomes are characterized by novel lncRNAs
(a) Schema of HSC and 9 lymphoid cell types in human bone marrow (BM) and thymus that 
were analyzed by RNA-Seq (n=20 samples [two biological replicates per population]). * 
Lineage cocktail included CD19 except in the case of BCP) (b) Bioinformatic analysis 
pipeline for annotating novel lncRNAs. (c) Number of expressed protein coding and long 
non-coding RNA genes (>1 FPKM in at least one sample). (d) Violin plot showing 
expression levels of protein coding and lncRNA genes (FPKM mean, standard deviation and 
range are depicted). For each gene the maximum expression value (of the 20 samples) was 
used to generate the plot. (e) Expression levels of novel lncRNA genes in BM and thymus 
samples, and 16 other cell types from the Human Body Map project (adipose, adrenal, 
breast, brain, colon, heart, kidney, leucocyte, liver, lung, lymph node, ovary, prostate, 
skeletal muscle, testis, thyroid, supplementary table 3). Shown are 357 genes differentially 
Casero et al. Page 14
Nat Immunol. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
expressed in at least one pairwise comparison of the 10 populations. HSC-hematopoietic 
stem cell, LMPP-lymphoid primed multipotent progenitor, CLP-common lymphoid 
progenitor, BCP- B committed progenitor. “Annotated lncRNA genes” were defined as 
genes annotated in GencodeV19 and/or lncipedia databases. “Novel lncRNA genes” were 
defined as lncRNA genes that have not been annotated in these databases. Hybrid lncRNA 
genes represent a subset of annotated lncRNA genes for which we discovered novel 
transcripts.
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Figure 2. LncRNAs transcription start sites (TSS) show cell type specific active chromatin 
profiles
(a) Histone modification profiles at TSSs of novel lncRNAs (ChiP-Seq data from 
hematopoietic stem and progenitor [CD133+] cells). (b) UCSC overlay tracks depicting 
representative novel lncRNAs overlapping histone modifications typically associated with 
enhancer (high H3K4Me1/ H3K4Me3 signal ratio) or promoter- (low H3K4Me1/ H3K4Me3 
signal ratio) elements. Overlay tracks depict the normalized Chip-Seq signal for HSPC 
(CD34+ and CD133+), CD19+ primary cells, and thymic cells (color code not shown). (c) 
H3K4Me1/ H3K4Me3 signal intensity ratios for protein coding genes and novel lncRNAs 
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for ChIP-Seq data from CD34+ mobilized peripheral blood cells, CD19+ primary B 
lymphocytes, and thymic cells. (d) ChIP-Seq metaplots (histone mark density) at TSSs of 
protein coding and lncRNA genes, stratified by gene expression level are depicted for 
CD34+ HSPC, CD19+ B lymphocytes, and unfractionated thymocytes; HSC, BCP, and 
Thy4 respectively represent the closest related cell types in the RNA-Seq dataset (see 
Supplementary Fig.3). “Highly expressed” was defined as the top 2,000 transcripts when all 
the transcripts are ranked by expression level in that cell type. Cell type “specific” 
transcripts were defined as those showing peak expression in that cell type, and the peak 
value exceeds twice the mean of the expression in all other cell types. Publically available 
ChIP-Seq datasets (Supplementary table 3) were used for the analysis of histone profiles.
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Figure 3. LncRNA genes are co-expressed with protein coding genes involved in hematopoiesis 
and immune function, during lymphoid differentiation
(a) Density histograms of pairwise Spearman expression correlations between genes from 
different classes, in trans or cis. (b) Gene ontology enrichment for protein coding genes in 
cis and positively correlated with lncRNA genes (mRNA – lncRNA rs > 0.8), other protein 
coding genes (mRNA – mRNA rs > 0.8), or negatively correlated (mRNA – lncRNA rs < 
−0.5, mRNA – mRNA rs < −0.5). Colormap indicates the –log10 hypergeometric p value for 
enrichment as provided by DAVID functional annotation tools. (c) Model-based expression 
profiles (Profiles 1–20, Group I–VII) of differentially expressed genes (protein coding and 
lncRNA genes) during lymphoid differentiation. Numbers above each plot indicate: Profile 
identifier number (Total number of genes in the profile; number of lncRNA genes in the 
profile). Group VII contains profiles that could not be assigned to a specific differentiation 
related pattern. * Profiles enriched for lncRNA genes (p<0.05 when compared with the 
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proportion of lncRNAs among all differe;ntially expressed genes). HSPC: hematopoietic 
stem/progenitor cells.
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Figure 4. Lymphoid commitment and differentiation are characterized by stage and lineage 
specific global lncRNA expression patterns
Sample clustering analysis based on differentially expressed genes (fold change >2 and 
FDR<5% for at least one pairwise comparison of the ten cell types). (a) All genes (protein 
coding and lncRNA genes); (b) Protein coding genes; (c) All lncRNA genes; and (d) Novel 
lncRNA genes. Profiles of protein coding genes cluster all CD34+ cells (HSC, LMPP, Thy 
1–3, CLP and BCP) separately from CD34neg (Thy4–6). In all analyses, CLP cluster with 
BCP (circled). LncRNA expression levels completely segregate B (CLP and BCP) and T 
lineage (Thy 1–6) lineages. Two biological replicates of each cell type are shown.
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Figure 5. LncRNA gene expression defines developmental relationships between bone marrow 
and thymic progenitors prior to complete lineage commitment, independent of protein coding 
gene expression
Bayesian polytomous model selection of (a) all genes (protein coding and lncRNA genes), 
and (b) lncRNA genes only, to analyze transcriptional differences between the least 
committed BM (HSC, LMPP, CLP) and thymic (Thy1, Thy2) progenitors. For a given 
combination of three cell types (depicted in column headers), each gene was assigned to 
either the null model (expression similar in all 3 cell types) or one of the alternative (non-
null) models (expression different in at least one, and possibly all, cell types, depicted to left 
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of rows 2–5). A, B and C represent the average expression of the gene in each of the three 
cell types. The null model is defined as A=B=C. The total number of genes classified in non-
null models (shown in the black circles along the top row both numerically and by relative 
size) for a given combination represents an inverse measure of the transcriptional proximity 
between the cell types in the combination. *For each combination, the proportion of 
classified genes assigned to each non-null model is indicated by both circle size and depth of 
color (yellow-green scale). Model selection for combinations containing cell types known to 
be either from distinct (HSC, BCP, and Thy4), or closely related lineages (Thy4, Thy5, and 
Thy6) was performed to estimate, within our dataset, the upper and lower bounds for the 
number of genes in the null model.
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Figure 6. Identifying lineage or differentiation stage specific, lncRNA-protein coding gene co-
expression modules
Weighted gene co-expression network analysis (WGCNA) across all samples (n=2 
biological replicates per cell type) was used to identify modules containing genes with 
highly correlated expression. a) Shown is WGCNA’s Topological Overlap Matrix (red: high 
expression correlation, yellow: low expression correlation) for genes in the 5 modules shown 
in b). (b) Lineage or differentiation stage specific (p<0.05 for expression specificity) 
modules with the depicted expression profiles were then selected. (c, d) Two suggested 
screening strategies for the identification of potentially interesting candidate lncRNA genes 
and lncRNA-protein coding gene co-expression associations within specific modules. 
Analyses of the hematopoietic stem and progenitor cell (HSPC) module are depicted in the 
form of circos plots (broken lines in the circumference indicate individual chromosomes) as 
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illustrative examples to demonstrate these strategies. (c) Coding to non-coding association: 
candidate lncRNA genes were identified based on high co-expression with protein coding 
genes in the HSPC module that belong to the functional annotation “proto-oncogenes” 
(includes genes known to be important for HSPC maintenance) (black circles). The three 
most positively (yellow circles, correlation coefficient >0) and negatively (orange circles, 
correlation coefficient <0) correlated lncRNA genes for each coding gene are shown. (d) 
Non-coding to coding association: Among genes with high module membership (module 
membership adjusted p value<0.01), the 10 most highly expressed lncRNA genes (black 
circles), and the 3 most positively (yellow circles) and negatively (orange circles) correlated 
protein coding genes for each of these lncRNA genes are shown.
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